abs306.txt	background		the	aim	of	this	study	was	to	identify	the	clinical	predictors	relatedto	the	risk	of	high-grade	papillary	bladder	cancer	before	first-timetransurethral	resection	of	a	bladder	tumor	(tur-bt)		and	to	develop	and	validatea	nomogram	predicting	the	risk	of	high-grade	papillary	bladder	cancer	methods		a	retrospective	clinical	study	of	consecutive	patients	who	underwentfirst-time	tur-bt	for	papillary	bladder	cancer	was	performed		medical	recordswere	reviewed	uniformly		and	the	following	data	were	collected		age		sex	episodes	of	urinary	symptoms		tumor	size		number	of	tumors		location	of	thelargest	tumor	(lateral	walls		base		posterior	wall		dome		and	anterior	wall)	tumor	appearance	(papillary	or	non-papillary		pedunculated	or	sessile)		andurinary	cytology		data	from	254	patients	(group	a)	were	used	for	the	developmentof	a	nomogram		while	data	from	170	patients	(group	b)	were	used	for	its	externalvalidation	results		high-grade	papillary	bladder	cancer	was	pathologically	diagnosed	in	51	6and	74	6%	of	group	a	and	group	b	patients		respectively		based	on	univariableanalyses	in	group	a		macrohematuria		tumor	size		multiple	tumors		appearance		andpositive	urinary	cytology	were	selected	as	variables	to	incorporate	into	anomogram		the	auc	value	was	0	81	for	the	internal	validation	(group	a)		and	0	78for	the	external	validation	(group	b)		this	novel	nomogram	can	predict	high-gradepapillary	bladder	cancer	accurately	conclusions		the	present	nomogram	can	help	clinicians	calculate	the	probabilityin	patients	with	bladder	cancer	before	tur-bt	and	decide	on	earlier	interventionand	priorities	for	the	treatment	of	patients	diagnosed	with	bladder	cancer	
